RBR-9dyq9jr尚未招募未知
Intervenções farmacêuticas sobre a complexidade da farmacoterapia em Idosos com doenças de risco cardiovascular: um ensaio clínico randomizado, controlado
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 60Y 至 0（—）
入选标准
- •Be 60 years of age or older; Carry out outpatient follow-up by outpatient physicians; Have at least one of the following diagnosed clinical conditions: systemic arterial hypertension, diabetes mellitus and dyslipidemia, according to the criteria recommended by the Brazilian guidelines for these clinical conditions; Present uncontrolled blood pressure and/or glycemic and/or lipid levels in accordance with established goals for the level of cardiovascular risk; Use medication for at least one of the chronic conditions mentioned above for more than six months
排除标准
- •Diagnosis of resistant or secondary systemic arterial hypertension; Diabetes and/or secondary dyslipidemia; End stage of kidney disease; Liver disease; Cancer treatment; Acquired immunodeficiency syndrome or anticoagulation; Unstable psychiatric illness; Service provided by other pharmacists; Inability to attend scheduled appointments; Missing in more than two consecutive appointments; Withdrawal from participating in the study at any stage
研究者
相似试验
尚未招募
不适用
Intervenções Farmacêuticas sobre o tratamento medicamentoso dos idosos com Doença de Risco CardiovascularPolypharmacyE02.319RBR-8dvw5zpFundação Universidade Federal de Sergipe
进行中（未招募）
1 期
ENSAYO ABIERTO, MULTICÉNTRICO, DE FARMACOCINÉTICA POR ADMINISTRACIÓN DE DOSIS MÚLTIPLES Y DE SEGURIDAD Y EFICACIA DE 48 SEMANAS DE MARAVIROC EN COMBINACIÓN CON UN TRATAMIENTO DE BASE OPTIMIZADO PARA EL TRATAMIENTO DE NIÑOS Y JÓVENES DE 2 A 18 AÑOS INFECTADOS POR EL VIH-1 CON TROPISMO CCR5 Y QUE YA HAN RECIBIDO TRATAMIENTO CON ANTIRRETROVIRALESAN OPEN-LABEL, MULTICENTER, MULTIPLE-DOSE PHARMACOKINETIC AND 48-WEEK SAFETY AND EFFICACY TRIAL OF MARAVIROC IN COMBINATION WITH OPTIMIZED BACKGROUND THERAPY FOR THE TREATMENT OF ANTIRETROVIRAL-EXPERIENCED CCR5-TROPIC HIV-1 INFECTED CHILDREN 2-18 YEARS OF AGETratamiento VIHMedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2008-006873-33-ESPfizer, S.A.125
进行中（未招募）
1 期
Ketamine to treat patients with post-comatose disorders of consciousnessDisorders of consciousness as Unresponsive Wakefulness Syndrome (UWS) and Minimally Conscious State (MCS) after a coma due to acquired brain injury.EUCTR2021-002321-23-BEniversity of Liège30
招募中
不适用
Reducing complexity of drug treatment in patients with polypharmacy while taking patient preferences into account in public pharmaciescomplexity of drug treatmentDRKS00025228Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik162
进行中（未招募）
1 期
ETUDE DE LA PHARMACOCINETIQUE DE L’ASSOCIATION PIPERACILLINE – TAZOBACTAM EN UTILISATION INTRA-VEINEUSE CONTINUE CHEZ L’ENFANT NEUTROPENIQUE FEBRILE .febrile episodes in neutropenic patientsMedDRA version: 9.1Level: LLTClassification code 10053223Term: Febrile aplasiaEUCTR2008-005131-15-FRCHRU de Lille20